1378 related articles for article (PubMed ID: 26401960)
1. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
2. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.
Barschke P; Oeckl P; Steinacker P; Ludolph A; Otto M
Expert Rev Proteomics; 2017 Sep; 14(9):769-777. PubMed ID: 28799854
[TBL] [Abstract][Full Text] [Related]
3. Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis.
Andrés-Benito P; Povedano M; Domínguez R; Marco C; Colomina MJ; López-Pérez Ó; Santana I; Baldeiras I; Martínez-Yelámos S; Zerr I; Llorens F; Fernández-Irigoyen J; Santamaría E; Ferrer I
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213069
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.
Ranganathan S; Nicholl GC; Henry S; Lutka F; Sathanoori R; Lacomis D; Bowser R
Amyotroph Lateral Scler; 2007 Dec; 8(6):373-9. PubMed ID: 17852009
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential CSF biomarkers in ALS.
Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
[TBL] [Abstract][Full Text] [Related]
6. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.
Ranganathan S; Williams E; Ganchev P; Gopalakrishnan V; Lacomis D; Urbinelli L; Newhall K; Cudkowicz ME; Brown RH; Bowser R
J Neurochem; 2005 Dec; 95(5):1461-71. PubMed ID: 16313519
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
9. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
[TBL] [Abstract][Full Text] [Related]
10. In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis.
Kroksveen AC; Guldbrandsen A; Vaudel M; Lereim RR; Barsnes H; Myhr KM; Torkildsen Ø; Berven FS
J Proteome Res; 2017 Jan; 16(1):179-194. PubMed ID: 27728768
[TBL] [Abstract][Full Text] [Related]
11. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
12. Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic.
von Neuhoff N; Oumeraci T; Wolf T; Kollewe K; Bewerunge P; Neumann B; Brors B; Bufler J; Wurster U; Schlegelberger B; Dengler R; Zapatka M; Petri S
PLoS One; 2012; 7(9):e44401. PubMed ID: 22970211
[TBL] [Abstract][Full Text] [Related]
13. A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.
Brinkmalm G; Sjödin S; Simonsen AH; Hasselbalch SG; Zetterberg H; Brinkmalm A; Blennow K
Proteomics Clin Appl; 2018 Jan; 12(1):. PubMed ID: 29028155
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients.
Conti A; Riva N; Pesca M; Iannaccone S; Cannistraci CV; Corbo M; Previtali SC; Quattrini A; Alessio M
Biochim Biophys Acta; 2014 Jan; 1842(1):99-106. PubMed ID: 24184715
[TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.
Kolarcik C; Bowser R
Mol Diagn Ther; 2006; 10(5):281-92. PubMed ID: 17022691
[TBL] [Abstract][Full Text] [Related]
16. Small peptide CSF fingerprint of amyotrophic lateral sclerosis.
Lumi R; Petri S; Siwy J; Latosinska A; Raad J; Zürbig P; Skripuletz T; Mischak H; Beige J
PLoS One; 2024; 19(4):e0302280. PubMed ID: 38687737
[TBL] [Abstract][Full Text] [Related]
17. [Proteomic analysis of the cerebrospinal fluid from patients with amyotrophic lateral sclerosis based on tandem mass spectrometry technique].
Su D; Zhang Y; Bi F; Xiao B
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):428-436. PubMed ID: 31068286
[TBL] [Abstract][Full Text] [Related]
18. Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid.
Vafadar-Isfahani B; Ball G; Coveney C; Lemetre C; Boocock D; Minthon L; Hansson O; Miles AK; Janciauskiene SM; Warden D; Smith AD; Wilcock G; Kalsheker N; Rees R; Matharoo-Ball B; Morgan K
J Alzheimers Dis; 2012; 28(3):625-36. PubMed ID: 22045497
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
